Actively Recruiting
Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism
Led by University of Reading · Updated on 2026-03-11
40
Participants Needed
1
Research Sites
85 weeks
Total Duration
On this page
Sponsors
U
University of Reading
Lead Sponsor
I
INNOPURE
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.
CONDITIONS
Official Title
Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between the ages of 18 to 60
- With a diagnosis of autism
You will not qualify if you...
- Taking any supplement that contains more than 2mg of Vitamin B6 or taking GABA agonist drugs
- Have a medical history of peripheral neuropathy
- Lactose intolerance (placebo tablet is lactose based)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Reading
Reading, United Kingdom, RG6 6AL
Actively Recruiting
Research Team
D
Dr David T Field, PhD
CONTACT
A
Alex Cameron, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here